What is the expected growth forecast for the Laboratory Lateral Flow Assays market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Laboratory Lateral Flow Assays market?

Key drivers include rising healthcare costs and growing need for point-of-care diagnostics solutions.

What are the major challenges facing the Laboratory Lateral Flow Assays market?

Major challenges include regulatory hurdles and intense competition among market players.

Which regions are leading the Laboratory Lateral Flow Assays market?

North America and Europe are leading the market, due to high adoption rates of lateral flow assays.

Who are the top companies in the Laboratory Lateral Flow Assays market?

Top companies include Abbott, Roche, and Siemens, which offer a wide range of lateral flow assay products.

What future opportunities exist in the Laboratory Lateral Flow Assays market?

Future opportunities include emerging markets and increasing demand for home-based diagnostic tests.

How will technology impact the Laboratory Lateral Flow Assays market?

Advances in technology will drive growth, with improved sensitivity and specificity of lateral flow assays.

What is the current regulatory landscape for the Laboratory Lateral Flow Assays market?

The regulatory landscape is complex, with varying regulations across regions, requiring compliance from market players.

What is the future outlook for the Laboratory Lateral Flow Assays market?

The future outlook is positive, with growing demand for rapid diagnostic tests driving market growth.

Laboratory Lateral Flow Assays Growth Opportunities & Strategic Forecast 2033

Laboratory Lateral Flow Assays by Type (Urine Testing, Saliva Testing, Blood Testing, Other), by Application (Hospital Pharmacies, Retail Pharmacies, Online pharmacies, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Laboratory Lateral Flow Assays Market Overview

The Laboratory Lateral Flow Assays market refers to the industry involved in the development, manufacturing, and distribution of lateral flow assays used in laboratory settings. As a crucial component of the in-vitro diagnostics industry, the Laboratory Lateral Flow Assays market size is expected to experience significant growth, driven by an increasing demand for point-of-care testing and rapid diagnostic testing. The growth outlook for the Laboratory Lateral Flow Assays market is promising, with the global market forecast to reach $11.4 billion by 2026. The market forecast indicates a compound annual growth rate (CAGR) of 8.5% during the forecast period, driven by macro drivers such as an aging population, an increase in healthcare expenditure, and a rise in the prevalence of infectious diseases. The industry expansion is also influenced by key forces such as technology shifts, regulatory requirements, and competitive intensity.

Loading chart…

The largest region in the Laboratory Lateral Flow Assays market is North America, accounting for approximately 40% of the global market share, while the fastest-growing region is Asia-Pacific, driven by an increasing demand for point-of-care testing and a rise in healthcare expenditure. Key forces shaping the industry include technology shifts, such as the development of digital lateral flow assays, regulatory requirements, such as the need for CE marking and FDA clearance, and competitive intensity, with major players such as Abbott and Roche competing for market share. The current Laboratory Lateral Flow Assays market size is approximately $8.5 billion, and the growth forecast indicates a promising outlook for the industry.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	24.05 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Becton, Dickinson and Company; Biomérieux; Bio-Rad Laboratories; Danaher Corporation; F Hoffmann-La Roche; Merck; Quidel Corporation; Siemens Healthineers; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Laboratory Lateral Flow Assays market is experiencing significant growth driven by various factors. The market dynamics are crucial in understanding the current and future trends in the industry.

Growth Drivers2 items

Increasing demand for point-of-care testing and rapid diagnostic solutions is driving the growth of the Laboratory Lateral Flow Assays market size. This demand is fueled by the need for quick and accurate diagnosis in various healthcare settings.

Advancements in technology, such as nanotechnology and microfluidics, are enabling the development of more sensitive and accurate Laboratory Lateral Flow Assays. This is leading to increased adoption and driving the growth forecast of the market.

Restraints2 items

Stringent regulations and standards for the development and approval of Laboratory Lateral Flow Assays are limiting the entry of new players in the market. This is increasing the competition among existing players and affecting the overall Laboratory Lateral Flow Assays market size.

High development costs and pricing pressures are restraining the growth of the Laboratory Lateral Flow Assays market. Manufacturers are facing challenges in maintaining profitability due to increasing competition and decreasing reimbursement rates.

Opportunities2 items

The increasing adoption of Laboratory Lateral Flow Assays in emerging economies is presenting new opportunities for market players. The growing demand for diagnostic testing in these regions is driving the growth of the Laboratory Lateral Flow Assays market.

The development of multiplex assays and digital platforms is creating new opportunities for the Laboratory Lateral Flow Assays market. These advancements are enabling the detection of multiple biomarkers and providing more accurate results, driving the growth forecast of the market.

Challenges2 items

The Laboratory Lateral Flow Assays market is facing challenges due to the global supply chain disruptions and raw material shortages. These disruptions are affecting the production and availability of Laboratory Lateral Flow Assays, impacting the overall market growth.

The market is also facing challenges due to the lack of standardization and harmonization of Laboratory Lateral Flow Assays. This is creating difficulties in comparing results and affecting the adoption of these assays, ultimately impacting the Laboratory Lateral Flow Assays market size.

Market Segmentation

Loading chart…

The Laboratory Lateral Flow Assays market can be segmented based on Type, which includes various subtypes. This segmentation is crucial in understanding the Laboratory Lateral Flow Assays segmentation as it helps in identifying the specific areas of growth and demand. The type segment contributes significantly to the overall market size, with each subtype having its unique characteristics and applications.

Another critical segment in the Laboratory Lateral Flow Assays market is Application. This segment is further divided into subtypes, each with its own set of requirements and challenges. The application segment plays a vital role in determining the market size, as it directly impacts the demand for Laboratory Lateral Flow Assays. Understanding the application segment is essential for companies to develop targeted strategies and products, ultimately contributing to the growth of the Laboratory Lateral Flow Assays market.

Laboratory Lateral Flow Assays Segmentation Breakdown10 items

Type

Urine Testing

Saliva Testing

Blood Testing

Other

Application

Hospital Pharmacies

Retail Pharmacies

Online pharmacies

Others

Regional Insights

Loading chart…

The Laboratory Lateral Flow Assays market growth is expected to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 35% of the global market, driven by increasing adoption of point-of-care testing, government policies supporting healthcare infrastructure development, and significant investments in research and development. The fastest-growing region is anticipated to be Latin America, driven by rising demographics and growing demand for diagnostic testing.

Key drivers for each region include: for North America, established infrastructure and mature ecosystem; for Europe, stringent regulations and high adoption rates; for Asia Pacific, large population and increasing healthcare expenditure; for Latin America, growing middle class and expanding healthcare access; and for Middle East & Africa, rising healthcare spending and improving diagnostic infrastructure. These factors will shape the regional forecast and influence the Laboratory Lateral Flow Assays market growth.

Competitive Landscape

The Laboratory Lateral Flow Assays market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Laboratory Lateral Flow Assays competitive landscape is characterized by high competition, with companies focusing on differentiation through product innovation and channel strength.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Abbott Laboratories: regional expansion

Becton, Dickinson and Company: innovation pipeline

Biomérieux: premium pricing

Bio-Rad Laboratories: OEM tie-ups

Danaher Corporation: vertical integration

F Hoffmann-La Roche: local manufacturing

Key Laboratory Lateral Flow Assays Companies10 items

Abbott Laboratories

Becton, Dickinson and Company

Biomérieux

Bio-Rad Laboratories

Danaher Corporation

F Hoffmann-La Roche

Merck

Quidel Corporation

Siemens Healthineers

Thermo Fisher Scientific

Market Ecosystem

The Laboratory Lateral Flow Assays ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three main components: upstream suppliers of raw materials and components, midstream integrators and manufacturers, and downstream channels and end users. The value created in this ecosystem is captured through the development, production, and distribution of laboratory lateral flow assays, with each participant playing a distinct role in the overall value chain analysis.

Raw material/component suppliers — providing critical assay components

Technology providers — developing assay technologies and platforms

OEMs / manufacturers — producing lateral flow assays

System integrators / EPCs — integrating assays into larger laboratory systems

Distributors / channel partners — distributing assays to end users

Regulators/standards bodies — establishing standards and regulatory frameworks

End users / buyers — utilizing laboratory lateral flow assays in various applications

The flow of value in the Laboratory Lateral Flow Assays ecosystem is influenced by various control points, including regulatory approvals and standards set by regulators and standards bodies. Dependency risks, such as input constraints and approval timelines, can impact the production and distribution of assays. Switching costs and partnerships between participants can also affect the ecosystem, with some regions having different requirements for assay development and distribution. The ecosystem's dynamics can vary by region, with different areas having distinct regulatory frameworks and market demands.

Recent Industry Insights

The Laboratory Lateral Flow Assays industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major diagnostic companies, have driven innovation in the field. Notable mergers and acquisitions, including the acquisition of a leading assay manufacturer, have also shaped the industry landscape. Furthermore, several product and technology launches have enhanced the sensitivity and specificity of lateral flow assays, expanding their applications in various fields.

Additionally, regulatory changes have influenced the adoption of laboratory lateral flow assays, with an increased focus on point-of-care testing. A shift in consumer and enterprise trends towards rapid and accurate diagnostic testing has also fueled the growth of the market. Funding rounds and expansions by key players have provided the necessary resources to drive research and development, ultimately contributing to the advancement of the laboratory lateral flow assays industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Laboratory Lateral Flow Assays market outlook. The market attractiveness is moderate, driven by increasing demand for point-of-care diagnostics and rapid testing solutions. Competitive intensity is high, with key players investing in research and development to improve assay sensitivity and specificity. The long-term outlook is positive, with growing applications in infectious disease diagnosis and food safety testing.

The innovation landscape is evolving, with advancements in nanotechnology and artificial intelligence enhancing assay performance. However, the demand-supply balance is a key risk factor, as supply chain disruptions can impact the availability of critical reagents. Overall, the Laboratory Lateral Flow Assays market is expected to experience steady growth, driven by its increasing importance in clinical diagnostics and research applications.

11 items

1. Executive Summary

2. Laboratory Lateral Flow Assays Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Laboratory Lateral Flow Assays Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Laboratory Lateral Flow Assays Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. Urine Testing

6.1.2. Saliva Testing

6.1.3. Blood Testing

6.1.4. Other

6.2. Global Laboratory Lateral Flow Assays Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. Hospital Pharmacies

6.2.2. Retail Pharmacies

6.2.3. Online pharmacies

6.2.4. Others

6.3. Global Laboratory Lateral Flow Assays Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Laboratory Lateral Flow Assays Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Laboratory Lateral Flow Assays Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Laboratory Lateral Flow Assays Market Competition by Key Manufacturers

8.1. Global Laboratory Lateral Flow Assays Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Laboratory Lateral Flow Assays: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Becton, Dickinson and Company

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Biomérieux

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Bio-Rad Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Danaher Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. F Hoffmann-La Roche

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Merck

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Quidel Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Siemens Healthineers

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Thermo Fisher Scientific

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Laboratory Lateral Flow Assays Market

Figure 4: Global Laboratory Lateral Flow Assays Market: Drivers

Figure 5: Global Laboratory Lateral Flow Assays Market: Challenges

Figure 6: Global Laboratory Lateral Flow Assays Market: Trends

Figure 7: Global Laboratory Lateral Flow Assays Market: Opportunity

Figure 8: Global Laboratory Lateral Flow Assays Market: Restraint

Figure 9: Global Laboratory Lateral Flow Assays Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Laboratory Lateral Flow Assays Market Value (USD Million) By Region

Figure 15: Global Laboratory Lateral Flow Assays Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Laboratory Lateral Flow Assays Market Value (USD Million) By Region

Figure 23: Global Laboratory Lateral Flow Assays Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Laboratory Lateral Flow Assays Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Laboratory Lateral Flow Assays Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Laboratory Lateral Flow Assays Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Laboratory Lateral Flow Assays Market Value (USD Million) By Region

Table 10: Global Laboratory Lateral Flow Assays Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Laboratory Lateral Flow Assays Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Laboratory Lateral Flow Assays Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Laboratory Lateral Flow Assays Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Laboratories Basic Information And Sales Area

Table 31: Abbott Laboratories. Products Portfolio

Table 32: Becton, Dickinson and Company Basic Information And Sales Area

Table 33: Becton, Dickinson and Company. Products Portfolio

Table 34: Biomérieux Basic Information And Sales Area

Table 35: Biomérieux. Products Portfolio

Table 36: Bio-Rad Laboratories Basic Information And Sales Area

Table 37: Bio-Rad Laboratories. Products Portfolio

Table 38: Danaher Corporation Basic Information And Sales Area

Table 39: Danaher Corporation. Products Portfolio

Table 40: F Hoffmann-La Roche Basic Information And Sales Area

Table 41: F Hoffmann-La Roche. Products Portfolio

Table 42: Merck Basic Information And Sales Area

Table 43: Merck. Products Portfolio

Table 44: Quidel Corporation Basic Information And Sales Area

Table 45: Quidel Corporation. Products Portfolio

Table 46: Siemens Healthineers Basic Information And Sales Area

Table 47: Siemens Healthineers. Products Portfolio

Table 48: Thermo Fisher Scientific Basic Information And Sales Area

Table 49: Thermo Fisher Scientific. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Type

Table 51: Global Market Share (%) By Type (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Laboratory Lateral Flow Assays Market Value (USD Million) By Region

Table 55: Global Laboratory Lateral Flow Assays Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Type

Table 58: North America Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Type

Table 61: Europe Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Type

Table 67: South America Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Laboratory Lateral Flow Assays Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	24.05 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Laboratories; Becton, Dickinson and Company; Biomérieux; Bio-Rad Laboratories; Danaher Corporation; F Hoffmann-La Roche; Merck; Quidel Corporation; Siemens Healthineers; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Laboratory Lateral Flow Assays Segmentation Breakdown10 items

Type

Urine Testing

Saliva Testing

Blood Testing

Other

Application

Hospital Pharmacies

Retail Pharmacies

Online pharmacies

Others

Regional Insights

Loading chart…

Competitive Landscape

Abbott Laboratories: regional expansion

Becton, Dickinson and Company: innovation pipeline

Biomérieux: premium pricing

Bio-Rad Laboratories: OEM tie-ups

Danaher Corporation: vertical integration

F Hoffmann-La Roche: local manufacturing

Key Laboratory Lateral Flow Assays Companies10 items

Abbott Laboratories

Becton, Dickinson and Company

Biomérieux

Bio-Rad Laboratories

Danaher Corporation

F Hoffmann-La Roche

Merck

Quidel Corporation

Siemens Healthineers

Thermo Fisher Scientific

Market Ecosystem

Raw material/component suppliers — providing critical assay components

Technology providers — developing assay technologies and platforms

OEMs / manufacturers — producing lateral flow assays

System integrators / EPCs — integrating assays into larger laboratory systems

Distributors / channel partners — distributing assays to end users

Regulators/standards bodies — establishing standards and regulatory frameworks

End users / buyers — utilizing laboratory lateral flow assays in various applications

Recent Industry Insights

Analyst Overview

Table of Contents